(Reuters) - The Texas attorney general has sued leading insulin manufacturers and pharmacy benefit managers (PBMs), accusing ...

For the most part, most insurances are accepted. KDKA-TV asked Point Park University Professor Dr. Archish Maharaja about ...

Texas Attorney General Ken Paxton has filed a lawsuit against several major insulin manufacturers and pharmacy benefit ...

Analysts at TD Cowen have raised their rating of CVS Health (NYSE:CVS) to "Buy" from "Hold", citing changes to its 2025 Medicare Advantage plan benefits announced earlier this week.

Number 3: Part 2 of our series diving into the Association for Accessible Medicines' (AAM) latest report discusses that while generics and biosimilars saved $445 billion in 2023, their potential is ...

UPMC said wants to make access to care outside of the emergency room more convenient and less costly, especially for ...

ManipalCigna Health Insurance has launched its new Sarvah health insurance plans, aiming to provide affordable and inclusive coverage for Bhar.

The state of Texas is accusing major pharmacy benefit managers and drug companies of colluding to raise the cost of insulin.

House Bill 596 aims to protect patients and pharmacies, by forcing pharmacy benefit managers to be more transparent with ...

UnitedHealth Group and Centene's Ambetter are expanding sales of individual coverage under the Affordable Care Act into ...

House Rep. Debbie Dingell introduced a bill that would expand dental coverage to tens of millions of Americans. The goal is ...

How supplies of GLP-1 drugs could be at risk as a result of the dockworker strike occurring across the East and Gulf coasts: ...